Steady Healthcare (300888.SZ) announced its 2023 annual results, net profit of 580 million yuan, a year-on-year decrease of 64.84%
Robust Healthcare (300888.SZ) released its 2023 annual results report. The company achieved operating income during the reporting period...
Winner Medical's (SZSE:300888) Returns On Capital Not Reflecting Well On The Business
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and se
Steady Healthcare (300888.SZ) has repurchased a total of 0.71% of its shares at a cost of 145 million yuan
Robust Healthcare (300888.SZ) announced that as of March 31, 2024, the company had repurchased a total of 41 shares...
Winner Medical Co., Ltd.'s (SZSE:300888) Intrinsic Value Is Potentially 18% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Winner Medical fair value estimate is CN¥30.00 Current share price of CN¥36.36 suggests Winner Medical is potentially 21% overvalued Analy
Steady Healthcare (300888.SZ) has repurchased a total of 3.635,900 shares at a cost of 125 million yuan
Robust Healthcare (300888.SZ) announced that as of February 29, 2024, the company is using centralized bidding transactions...
Winner Medical Co., Ltd.'s (SZSE:300888) Top Holders Are Insiders and They Are Likely Disappointed by the Recent 3.2% Drop
Key Insights Insiders appear to have a vested interest in Winner Medical's growth, as seen by their sizeable ownership Jian Li owns 69% of the company Using data from analyst forecasts alongside o
These 4 Measures Indicate That Winner Medical (SZSE:300888) Is Using Debt Reasonably Well
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Robust Healthcare (300888.SZ): Initial repurchase of 646,600 shares involving 1999.92 million yuan
Gelonghui, Feb. 2 | Robust Healthcare (300888.SZ) announced that on February 2, 2024, for the first time, the company repurchased 646,600 shares of the company's shares through a dedicated securities account, accounting for 0.1088% of the company's total share capital. The highest transaction price was 31.91 yuan/share, the minimum transaction price was 30.01 yuan/share, and the total transaction amount was 1999.92 million yuan (not including transaction fees).
Steady Healthcare (300888.SZ): In 2023, store operating efficiency improved, and store floor efficiency increased by about 15% year-on-year
Gelonghui, Feb. 1 | Steady Healthcare (300888.SZ) revealed that in 2023, store operating efficiency improved, and store floor efficiency achieved a year-on-year increase of about 15%, mainly in the following areas of work: First, we selected the store type. According to the different store types, we made more detailed plans, appropriately adjusted and reduced the types of large stores that needed to be improved in efficiency, and expanded potential store types with better profitability under 300 square meters. Second, in terms of quality and efficiency, digital management has been strengthened, focusing on explosive products, and displayed around three major scenarios to reduce the delay of long-tail SKUs
Steady Healthcare (300888.SZ): In the 2023 Cotton Era, the number of members increased by 9.08 million, an increase of 16% year-on-year
Gelonghui Feb. 1 | Robust Healthcare (300888.SZ) revealed a record sheet of investor relations activities, showing that judging from the 2023 operating results, market performance is more of a trend where consumption is stratified, and consumers are becoming more and more refined. The number of members in the 2023 Cotton Era increased by 9.08 million, an increase of 16% over the previous year; the total number of high-value members spending more than 2,000 yuan a year, the member repurchase rate, and the average monthly membership consumption frequency have all increased, which can be seen as an increase in overall membership stickiness. On the other hand, due to consumer prudence, consumers' mentality to stock up weakens, and they will buy in installments, and the customer unit price will be affected as a result
Robust Healthcare (300888.SZ): Net profit is expected to drop 51.53% to 58.8% year on year in 2023
On January 30, Gelonghui | Robust Healthcare (300888.SZ) announced that net profit is expected to be 68,000.00 to 800,000 yuan in 2023, down 51.53% to 58.80% year on year, after deducting 51,000.00 to 60.00 million yuan in non-net profit, down 61.56% to 67.33% year on year. In 2023, the company achieved cumulative operating revenue of 8.06 billion yuan to 8.26 billion yuan, a year-on-year decrease of 27.23% to 29.00%. Because of the company and Shenzhen Xingda Real Estate Development Co., Ltd. (hereinafter referred to as “Xingda Company”
Robust Healthcare (300888.SZ): Overseas business is mainly in Europe, Japan, the United States and other countries
Gelonghui, January 24 | Robust Healthcare (300888.SZ) said on the interactive platform that our overseas business is mainly in Europe, Japan, the US, etc., and the mentioned regions have no obvious impact on the company's overall sales situation.
Winner Medical Co., Ltd.'s (SZSE:300888) Price Is Right But Growth Is Lacking
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 32x, you may consider Winner Medical Co., Ltd. (SZSE:300888) as a highly attractive investment with its 8.6x
Robust Healthcare (300888.SZ): Successfully developed and launched silicone gel foam dressings and foam dressings, suitable for the care of the elderly with chronic diseases
Gelonghui, January 9 | Robust Healthcare (300888.SZ) said on an interactive platform that with the increase in global demand for aging care, the company saw market opportunities and developed a variety of age-appropriate products. In terms of high-end dressings, the company successfully developed and launched silicone gel foam dressings and foam dressings, which are suitable for the care of the elderly with chronic diseases, accelerate wound healing, make drug changes painless, provide patients with cost-effective solutions for chronic wound treatment, and effectively solve clinical pain points such as adhering wounds and frequent drug changes with traditional gauze dressings. In addition, the company has set up a “light skin” adult incontinence care sub-brand, which is mild incontinence and moderate incontinence
Winner Medical (SZSE:300888) Will Be Hoping To Turn Its Returns On Capital Around
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding
A Look At The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)
Key Insights Winner Medical's estimated fair value is CN¥36.16 based on 2 Stage Free Cash Flow to Equity Current share price of CN¥37.51 suggests Winner Medical is potentially trading close to its f
Will Weakness in Winner Medical Co., Ltd.'s (SZSE:300888) Stock Prove Temporary Given Strong Fundamentals?
Winner Medical (SZSE:300888) has had a rough week with its share price down 2.5%. However, stock prices are usually driven by a company's financial performance over the long term, which in this case
[Instant Analysis of BT Financial Report] Robust Healthcare 2023 Third Quarter Report: Net profit has increased dramatically, and the decline in net cash flow has attracted attention
Announcement time of this financial report: 2023-10-23 20:00:41 Robust Healthcare (stock code: 300888) is a company focusing on the medical field. Its main business includes R&D, production and sales of medical equipment. According to the 2023 three-quarter report, the company obtained certain investment income and other benefits in the first half of the year, but whether these benefits are sustainable still requires further observation and analysis. In terms of assets and liabilities, Robust Healthcare's total assets at the end of the third quarter of 2023 were 19.059 billion yuan, up from 18.363 billion yuan at the end of the previous year. Total liabilities
Robust Healthcare (300888.SZ): It is proposed to use no more than 500 million yuan of idle raised capital for cash management
Glonghui, Oct. 23, 丨 Steady Healthcare (300888.SZ) announced that on October 23, 2023, the company held the 17th meeting of the 3rd board of directors and the 12th meeting of the 3rd board of supervisors to deliberate and pass the “Proposal on Using Part of Idle Raised Funds for Cash Management”. The resolution, without affecting the normal progress of fund-raising investment plans and the safety of raised funds, agreed that the company would use no more than 500 million yuan of idle funds for cash management. The period of use is valid for 12 months from the date of review and approval by the board of directors. Within the above amount and period, funds can be used on a rolling basis,
Robust Healthcare (300888.SZ) released results for the first three quarters, with net profit of 2.148 billion yuan, an increase of 71.78%
Robust Healthcare (300888.SZ) released its report for the third quarter of 2023. The company's revenue for the first three quarters was 6...
No Data